What is Vivid Vision?
Vivid Vision operates at the intersection of ophthalmology and virtual reality, providing a specialized platform designed to treat binocular vision dysfunctions. The company's core offerings address conditions such as lazy eye, crossed eye, and convergence insufficiency through a dual-delivery model that supports both in-clinic professional oversight and at-home patient engagement. By utilizing interactive VR environments, the platform facilitates neuroplasticity-based exercises that are both engaging and clinically effective. This hybrid approach allows eye care professionals to monitor patient progress with precision, effectively digitizing traditional vision therapy and expanding access to high-quality care for patients across all age demographics.
How much funding has Vivid Vision raised?
Vivid Vision has raised a total of $2.6M across 3 funding rounds:
Angel/Seed
$2.2M
Debt
$150K
Debt
$224K
Angel/Seed (2017): $2.2M with participation from The VR Fund, SOS Ventures, Liquid 2 Ventures, CRCM Ventures, and Anorak Ventures
Debt (2020): $150K led by PPP
Debt (2021): $224K supported by PPP
Key Investors in Vivid Vision
The VR Fund
A global investment firm focused on the intersection of immersive, spatial, and intelligent computing, supporting founders building the future of interactive experiences.
SOS Ventures
A venture capital and private equity firm based in Connecticut that provides strategic support and capital to early-stage technology companies.
Liquid 2 Ventures
An investment firm that supports exceptional founders through community and capital, focusing on early-stage opportunities across all technology sectors.
What's next for Vivid Vision?
With the recent influx of capital, Vivid Vision is well-positioned to scale its enterprise-level operations and deepen its integration within the global eye care ecosystem. The strategic focus will likely shift toward expanding its clinical footprint and enhancing the data-driven capabilities of its software, which is essential for maintaining its competitive edge in the MedTech sector. As the company matures, the emphasis will remain on securing broader adoption among eye care practitioners, thereby solidifying its role as a standard-bearer for digital vision rehabilitation. Future growth will be predicated on the company's ability to demonstrate long-term clinical outcomes while navigating the regulatory requirements inherent in the healthcare technology space.
See full Vivid Vision company page
